Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis

Journal of Infectious Diseases

Volumn 192, Issue 1, 2005, Pages 79-88

  Thwaites, Guy E ^a,d,e   Lan, Nguyen Thi Ngoc ^b   Dung, Nguyen Huy ^b   Quy, Hoang Thi ^b   Oanh, Do Thi Tuong ^b   Thoa, Nguyen Thi Cam ^b   Hien, Nguyen Quang ^b   Thuc, Nguyen Tri ^b   Hai, Nguyen Ngoc ^b   Bang, Nguyen Duc ^b   Lan, Nguyen Ngoc ^b   Duc, Nguyen Hong ^b   Tuan, Vu Ngoc ^b   Hiep, Cao Huu ^b   Chau, Tran Thi Hong ^c   Mai, Pham Phuong ^c   Dung, Nguyen Thi ^c   Stepniewska, Kasia ^d   White, Nicholas J ^a,d   Hien, Tran Tinh ^c   Farrar, Jeremy J ^a,d   more..

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b Pham Ngoc Thach Hospital   (Viet Nam)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

EID: 20844457155     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430616     Document Type: Article

References (19)

1. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. Geneva: WHO, 2004.
2. Mitchison DA. Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2000; 4:796-806.
3. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133:423-30.
4. Ellard GA, Humphries MJ, Allen BW. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993; 148:650-5.
5. Donald PR, Sirgel FA, Botha FJ, et al. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am J Respir Crit Care Med 1997; 156:895-900.
6. Bobrowitz ID. Ethambutol in tuberculous meningitis. Chest 1972; 61: 629-32.
7. Thwaites GE, Chau TT, Caws M, et al. Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis 2002; 6:865-71.
8. Thwaites GE, Caws M, Chau TT, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 2004; 42: 996-1002.
9. Patel VB, Padayatchi N, Bhigjee AI, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004; 38:851-6.
10. Daikos GL, Cleary T, Rodriguez A, Fischl MA. Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis 2003; 7:394-8.
11. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351:1741-51.
12. Thwaites GE, Simmons CP, Than Ha Quyen N, et al. Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis. J Infect Dis 2003;188:1105-15.
13. Collins CH, Grange JM, Yates MD. Tuberculous bacteriology: organisation and practice. 2nd ed. Oxford: Butterworth-Heinemann, 1997.
14. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 2:81-4.
15. van Soolingen D, de Haas PE, van Doom HR, Kuijper E, Rinder H, Borgdorff MW. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands. J Infect Dis 2000; 182:1788-90.
16. DeVincenzo JP, Berning SE, Peloquin CA, Husson RN. Multidrug-resistant tuberculosis meningitis: clinical problems and concentrations of second-line antituberculous medications. Ann Pharmacother 1999; 33:1184-8.
17. Berning SE, Cherry TA, Iseman MD. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis 2001; 32: 643-6.
18. Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother 2003;47:2231-5.
19. Johansen IS, Lundgren B, Sosnovskaja A, Thomsen Vs VO. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 2003;41:4454-6.